Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov;31 Suppl 26(Suppl 26):102-104.
doi: 10.1111/pai.13346.

Telemedicine for allergic patients during COVID-19

Affiliations

Telemedicine for allergic patients during COVID-19

Stefano Pattini et al. Pediatr Allergy Immunol. 2020 Nov.

Abstract

In the last few years, we have witnessed an important development in the medical field of both Mobile Health, such as the use of mobile communication devices, and other telemedicine tools in general, in order to support the surveillance of diseases from the moment of the first diagnosis to the therapeutic follow-up. Long before COVID-19, some authors had analyzed various possible evidence-based scenarios and had indicated how the use of telemedicine could prove to be extremely useful in epidemic situations, especially for the management of chronic patients, such as immune-allergic ones, who are notoriously in greater need of regular follow-up; however, as expected, the advent of the COVID-19 pandemic has amplified the differences between various countries, from the point of view of the propensity to use technological solutions in the health sector. The hope is that one positive outcome of the ongoing pandemic is that it will lead to an acceleration, by all the stakeholders involved, of the process of modernization of health care.

Keywords: COVID-19; apps; contact tracing; immune-allergic patients; telemedicine.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflict of interest to declare.

Similar articles

Cited by

  • Recent developments in the immunopathology of COVID-19.
    Zhang HP, Sun YL, Wang YF, Yazici D, Azkur D, Ogulur I, Azkur AK, Yang ZW, Chen XX, Zhang AZ, Hu JQ, Liu GH, Akdis M, Akdis CA, Gao YD. Zhang HP, et al. Allergy. 2023 Feb;78(2):369-388. doi: 10.1111/all.15593. Epub 2022 Dec 5. Allergy. 2023. PMID: 36420736 Free PMC article. Review.
  • Digital tools in allergy and respiratory care.
    Verhoeven E, Rouadi P, Jaoude EA, Abouzakouk M, Ansotegui I, Al-Ahmad M, Al-Nesf MA, Azar C, Bahna S, Cuervo-Pardo L, Diamant Z, Douagui H, Maximiliano Gómez R, Díaz SG, Han JK, Idriss S, Irani C, Karam M, Klimek L, Nsouli T, Scadding G, Senior B, Smith P, Yáñez A, Zaitoun F, Hellings PW. Verhoeven E, et al. World Allergy Organ J. 2022 Jun 23;15(7):100661. doi: 10.1016/j.waojou.2022.100661. eCollection 2022 Jul. World Allergy Organ J. 2022. PMID: 35784945 Free PMC article. Review.
  • Comments on metabolomics in asthma and atopic dermatitis, and patient care during the COVID-19 pandemic.
    Eigenmann P. Eigenmann P. Pediatr Allergy Immunol. 2021 Nov;32(8):1597-1600. doi: 10.1111/pai.13664. Pediatr Allergy Immunol. 2021. PMID: 34719820 Free PMC article. No abstract available.

References

    1. Matricardi PM, Dramburg S, Alvarez‐Perea A, et al. The role of mobile health technologies in allergy care: an EAACI position paper. Allergy. 2020;75:259‐272. - PubMed
    1. Flodgren G, Rachas A, Farmer AJ, et al. Interactive telemedicine: effects on professional practice and health care outcomes. Cochrane Database Syst Rev. 2015;CD002098. - PMC - PubMed
    1. Ohannessian R. Telemedicine: Potential applications in epidemic situations. Eur Res Telemed. 2015;4:95‐98.
    1. Ohannessian R, Duong TA, Odone A. Global Telemedicine implementation and integration within health systems to fight the COVID‐19 pandemic: a call to action. JMIR Public Health Surveill. 2020;6:e18810. - PMC - PubMed
    1. Portnoy J, Waller M, Elliott T. Telemedicine in the era of COVID‐19. J Allergy Clin Immunol Pract. 2020;8:1489‐1491. - PMC - PubMed